Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies

Staging of brain pathology related to sporadic Parkinson’s disease

Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · see citing works

α-Synuclein in Lewy bodies

Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382 · see citing works

Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240 · see citing works

α-Synuclein Locus Triplication Causes Parkinson's Disease

Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383 · see citing works

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis

Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064 · see citing works

AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease

Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836 · see citing works

The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia

Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737 · see citing works

Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice

Luk, K. C., Kehm, V., Carroll, J., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M.-Y. (2012) · Science · doi:10.1126/science.1227157 · Cited by 2,563 · see citing works

α-synuclein locus duplication as a cause of familial Parkinson's disease

Chartier-Harlin, M.-C., Kachergus, J., Roumier, C., Mouroux, V., Douay, X., Lincoln, S., Levecque, C., Larvor, L., Andrieux, J., Hulihan, M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17103-1 · Cited by 2,029 · see citing works

α-Synuclein is phosphorylated in synucleinopathy lesions

Fujiwara, H., Hasegawa, M., Dohmae, N., Kawashima, A., Masliah, E., Goldberg, M., Shen, J., Takio, K., & Iwatsubo, T. (2002) · Nature Cell Biology · doi:10.1038/ncb748 · Cited by 1,906 · see citing works

Stabilization of α-Synuclein Secondary Structure upon Binding to Synthetic Membranes

Davidson, W. S., Jonas, A., Clayton, D. F., & George, J. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.16.9443 · Cited by 1,588 · see citing works

Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death

Volpicelli-Daley, L. A., Luk, K. C., Patel, T. P., Tanik, S. A., Riddle, D. M., Stieber, A., Meaney, D. F., Trojanowski, J. Q., & Lee, V. M.-Y. (2011) · Neuron · doi:10.1016/j.neuron.2011.08.033 · Cited by 1,569 · see citing works

Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy

Conway, K. A., Lee, S., Rochet, J., Ding, T. T., Williamson, R. E., & Lansbury, P. T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.571 · Cited by 1,543 · see citing works

Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease

Conway, K. A., Harper, J. D., & Lansbury, P. T. (1998) · Nature Medicine · doi:10.1038/3311 · Cited by 1,501 · see citing works

Phosphorylation of Ser-129 Is the Dominant Pathological Modification of α-Synuclein in Familial and Sporadic Lewy Body Disease

Anderson, J. P., Walker, D., Goldstein, J. M., de Laat, R., Banducci, K., Caccavello, R. J., Barbour, R., Huang, J., Kling, K., Lee, M., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600933200 · Cited by 1,418 · see citing works

Alpha-synuclein and neurodegenerative diseases

Goedert, M. (2001) · Nature reviews. Neuroscience · doi:10.1038/35081564 · Cited by 1,402 · see citing works

The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system

Iwai, A., Masliah, E., Yoshimoto, M., Ge, N., Flanagan, L., Rohan de Silva, H. A., Kittel, A., & Saitoh, T. (1995) · Neuron · doi:10.1016/0896-6273(95)90302-x · Cited by 1,316 · see citing works

Modification of Parkinsonism — Chronic Treatment with L-Dopa

Cotzias, G. C., Papavasiliou, P. S., & Gellene, R. A. (1969) · New England Journal of Medicine · doi:10.1056/nejm196902132800701 · Cited by 1,287 · see citing works

Neuronal α-Synucleinopathy with Severe Movement Disorder in Mice Expressing A53T Human α-Synuclein

Giasson, B. I., Duda, J. E., Quinn, S. M., Zhang, B., Trojanowski, J. Q., & Lee, V. M.-Y. (2002) · Neuron · doi:10.1016/s0896-6273(02)00682-7 · Cited by 1,266 · see citing works

Aggregated α‐synuclein activates microglia: a process leading to disease progression in Parkinson's disease

Zhang, W., Wang, T., Pei, Z., Miller, D. S., Wu, X., Block, M. L., Wilson, B., Zhang, W., Zhou, Y., Hong, J.-S., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-2751com · Cited by 1,265 · see citing works

100 years of Lewy pathology

Goedert, M., Spillantini, M. G., Del Tredici, K., & Braak, H. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.242 · Cited by 1,190 · see citing works

α-Synuclein strains cause distinct synucleinopathies after local and systemic administration

Peelaerts, W., Bousset, L., Van der Perren, A., Moskalyuk, A., Pulizzi, R., Giugliano, M., Van den Haute, C., Melki, R., & Baekelandt, V. (2015) · Nature · doi:10.1038/nature14547 · Cited by 1,130 · see citing works

Cell-produced α-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival

Emmanouilidou, E., Melachroinou, K., Roumeliotis, T., Garbis, S. D., Ntzouni, M., Margaritis, L. H., Stefanis, L., & Vekrellis, K. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5699-09.2010 · Cited by 1,115 · see citing works

Evidence for a Partially Folded Intermediate in α-Synuclein Fibril Formation

Uversky, V. N., Li, J., & Fink, A. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010907200 · Cited by 1,096 · see citing works

Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice

Luk, K. C., Kehm, V. M., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M. ‐. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20112457 · Cited by 1,087 · see citing works

Identification of two distinct synucleins from human brain

Jakes, R., Spillantini, M. G., & Goedert, M. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00395-5 · Cited by 1,080 · see citing works

A Hydrophobic Stretch of 12 Amino Acid Residues in the Middle of α-Synuclein Is Essential for Filament Assembly

Giasson, B. I., Murray, I. V. J., Trojanowski, J. Q., & Lee, V. M.-Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008919200 · Cited by 1,080 · see citing works

Conformational properties of α-synuclein in its free and lipid-associated states 1 1Edited by P. E. Wright

Eliezer, D., Kutluay, E., Bussell, R., & Browne, G. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4538 · Cited by 1,077 · see citing works

Parkinson's disease: a dual‐hit hypothesis

Hawkes, C. H., Del Tredici, K., & Braak, H. (2007) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2007.00874.x · Cited by 1,021 · see citing works

Clinical progression in Parkinson disease and the neurobiology of axons

Cheng, H., Ulane, C. M., & Burke, R. E. (2010) · Annals of Neurology · doi:10.1002/ana.21995 · Cited by 1,012 · cited 3× · see citing works

α-Synuclein Cooperates with CSPα in Preventing Neurodegeneration

Chandra, S. S., Gallardo, G., Fernández‐Chacón, R., Schlüter, O. M., & Südhof, T. C. (2005) · Cell · doi:10.1016/j.cell.2005.09.028 · Cited by 967 · see citing works

Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease

Boeve, B. F., Silber, M. H., Saper, C. B., Ferman, T. J., Dickson, D. W., Parisi, J. E., Benarroch, E. E., Ahlskog, J. E., Smith, G. E., Caselli, R., et al. (2007) · Brain · doi:10.1093/brain/awm056 · Cited by 960 · see citing works

Exogenous α-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells

Luk, K. C., Song, C., O’Brien, P., Stieber, A., Branch, J. R., Brunden, K. R., Trojanowski, J. Q., & Lee, V. M. ‐. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908005106 · Cited by 958 · see citing works

Mitochondrial dysfunction and oxidative stress in Parkinson's disease

Subramaniam, S., & Chesselet, M. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.04.004 · Cited by 925 · see citing works

Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders

Arizona Parkinson’s Disease Consortium, Beach, T. G., Adler, C. H., Sue, L. I., Vedders, L., Lue, L., White III, C. L., Akiyama, H., Caviness, J. N., Shill, H. A., et al. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0664-3 · Cited by 911 · see citing works

Direct Observation of the Interconversion of Normal and Toxic Forms of α-Synuclein

Cremades, N., Cohen, S. I. A., Deas, E., Abramov, A. Y., Chen, A. Y., Orte, Á., Sandal, M., Clarke, R. W., Dunne, P., Aprile, F. A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.037 · Cited by 901 · see citing works

Direct Transfer of α-Synuclein from Neuron to Astroglia Causes Inflammatory Responses in Synucleinopathies

Lee, H.-J., Suk, J.-E., Patrick, C., Bae, E.-J., Cho, J.-H., Rho, S., Hwang, D., Masliah, E., & Lee, S.-J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.081125 · Cited by 877 · see citing works

Prion-like spreading of pathological α-synuclein in brain

Masuda-Suzukake, M., Nonaka, T., Hosokawa, M., Oikawa, T., Arai, T., Akiyama, H., Mann, D. M. A., & Hasegawa, M. (2013) · Brain · doi:10.1093/brain/awt037 · Cited by 867 · see citing works

Single nigrostriatal dopaminergic neurons form widely spread and highly dense axonal arborizations in the neostriatum

Matsuda, W., Furuta, T., Nakamura, K. C., Hioki, H., Fujiyama, F., Arai, R., & Kaneko, T. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4029-08.2009 · Cited by 865 · see citing works

Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia

Kim, C., Ho, D.-H., Suk, J.-E., You, S., Michael, S., Kang, J., Joong Lee, S., Masliah, E., Hwang, D., Lee, H.-J., et al. (2013) · Nature Communications · doi:10.1038/ncomms2534 · Cited by 856 · see citing works

Exosomal cell-to-cell transmission of alpha synuclein oligomers

Danzer, K. M., Kranich, L. R., Ruf, W. P., Cagsal‐Getkin, O., Winslow, A. R., Zhu, L., Vanderburg, C. R., & McLean, P. J. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-42 · Cited by 852 · see citing works

Characterization of a novel protein regulated during the critical period for song learning in the zebra finch

George, J. M., Jin, H., Woods, W. S., & Clayton, D. F. (1995) · Neuron · doi:10.1016/0896-6273(95)90040-3 · Cited by 844 · see citing works

Intravesicular Localization and Exocytosis of α-Synuclein and its Aggregates

Lee, H.-J., Patel, S. S., & Lee, S. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.0692-05.2005 · Cited by 798 · see citing works

Fibrils Formed in Vitro from α-Synuclein and Two Mutant Forms Linked to Parkinson's Disease are Typical Amyloid

Conway, K. A., Harper, J. D., & Lansbury, P. T. (2000) · Biochemistry · doi:10.1021/bi991447r · Cited by 786 · see citing works

Where Does Parkinson Disease Pathology Begin in the Brain?

Del Tredici, K., Rüb, U., de Vos, R. A. I., Bohl, J. R. E., & Braak, H. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.5.413 · Cited by 773 · see citing works

Fiber diffraction of synthetic α-synuclein filaments shows amyloid-like cross-β conformation

Serpell, L. C., Berriman, J. A., Jakes, R., Goedert, M., & Crowther, R. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.9.4897 · Cited by 748 · see citing works

Parkinson-Like Neurodegeneration Induced by Targeted Overexpression of α-Synuclein in the Nigrostriatal System

Kirik, D., Rosenblad, C., Bürger, C., Lundberg, C., Johansen, T. E., Muzyczka, N., Mandel, R. J., & Björklund, A. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02780.2002 · Cited by 730 · see citing works

α-Synuclein Fibrillogenesis Is Nucleation-dependent

Wood, S. J., Wypych, J., Steavenson, S., Louis, J., Citron, M., & Biere, A. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19509 · Cited by 719 · see citing works

Both Familial Parkinson's Disease Mutations Accelerate α-Synuclein Aggregation

Narhi, L. O., Wood, S. J., Steavenson, S., Jiang, Y., Wu, G. M., Anafi, D., Kaufman, S. A., Martin, F. H., Sitney, K. C., Denis, P., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.14.9843 · Cited by 710 · see citing works

Comparison of kindreds with parkinsonism and α‐synuclein genomic multiplications

Farrer, M. J., Kachergus, J. M., Forno, L. S., Lincoln, S., Wang, D., Hulihan, M., Maraganore, D. M., Gwinn, K. A., Wszołek, Z. K., Dickson, D. W., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10846 · Cited by 699 · see citing works

G51D α‐synuclein mutation causes a novel Parkinsonian–pyramidal syndrome

Lesage, S., Anheim, M., Letournel, F., Bousset, L., Honoré, A., Rozas, N., Pieri, L., Madiona, K., Dürr, A., Melki, R., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23894 · Cited by 697 · see citing works

Distinct α-Synuclein Strains Differentially Promote Tau Inclusions in Neurons

Guo, J. L., Covell, D. J., Daniels, J. P., Iba, M., Stieber, A., Zhang, B., Riddle, D. M., Kwong, L. K., Xu, Y., Trojanowski, J. Q., et al. (2013) · Cell · doi:10.1016/j.cell.2013.05.057 · Cited by 680 · see citing works

Alpha‐synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease

Appel‐Cresswell, S., Vilariño‐Güell, C., Encarnacion, M. J., Sherman, H. E., Yu, I. S., Shah, B., Weir, D. M., Thompson, C., Szu‐Tu, C., Trinh, J., et al. (2013) · Movement Disorders · doi:10.1002/mds.25421 · Cited by 669 · see citing works

THE BIOCHEMISTRY OF PARKINSON'S DISEASE

Cookson, M. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133400 · Cited by 659 · see citing works

Stanley Fahn Lecture 2005: the staging procedure for the inclusion body pathology associated with sporadic Parkinson’s disease reconsidered

Braak, H., Bohl, J. R., Müller, C. M., Rüb, U., de Vos, R. A. I., & Del Tredici, K. (2006) · Movement Disorders · doi:10.1002/mds.21065 · Cited by 630 · see citing works

Lewy body extracts from Parkinson disease brains trigger α‐synuclein pathology and neurodegeneration in mice and monkeys

Recasens, A., Dehay, B., Bové, J., Carballo‐Carbajal, I., Doveró, S., Pérez‐Villalba, A., Fernagut, P., Blesa, J., Parent, A., Perier, C., et al. (2013) · Annals of Neurology · doi:10.1002/ana.24066 · Cited by 629 · see citing works

Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies

Codolo, G., Plotegher, N., Pozzobon, T., Brucale, M., Tessari, I., Bubacco, L., & de Bernard, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055375 · Cited by 585 · see citing works

Presynaptic α-Synuclein Aggregates, Not Lewy Bodies, Cause Neurodegeneration in Dementia with Lewy Bodies

Kramer, M. L., & Schulz-Schaeffer, W. J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4564-06.2007 · Cited by 571 · see citing works

Biochemical aspects of Parkinson's disease

Hornykiewicz, O. (1998) · Neurology · doi:10.1212/wnl.51.2_suppl_2.s2 · Cited by 563 · see citing works

Afferent projections to the rat locus coeruleus as determined by a retrograde tracing technique

Cedarbaum, J. M., & Aghajanian, G. K. (1978) · The Journal of Comparative Neurology · doi:10.1002/cne.901780102 · Cited by 549 · see citing works

A novel α-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson's disease-type pathology

Pasanen, P., Myllykangas, L., Siitonen, M., Raunio, A., Kaakkola, S., Lyytinen, J., Tienari, P. J., Pöyhönen, M., & Paetau, A. E. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.03.024 · Cited by 535 · see citing works

α-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease

Bianco, C. L., Ridet, J.-L., Schneider, B. L., Déglon, N., & Aebischer, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152339799 · Cited by 533 · see citing works

Effect of Familial Parkinson's Disease Point Mutations A30P and A53T on the Structural Properties, Aggregation, and Fibrillation of Human α-Synuclein

Li, J., Uversky, V. N., & Fink, A. L. (2001) · Biochemistry · doi:10.1021/bi010616g · Cited by 513 · see citing works

Mutant and Wild Type Human α-Synucleins Assemble into Elongated Filaments with Distinct Morphologies in Vitro

Giasson, B. I., Uryu, K., Trojanowski, J. Q., & Lee, V. M. ‐. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7619 · Cited by 505 · see citing works

Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease

Berg, D., Postuma, R. B., Bloem, B. R., Chan, P., Dubois, B., Gasser, T., Goetz, C. G., Halliday, G. M., Hardy, J., Lang, A. E., et al. (2014) · Movement Disorders · doi:10.1002/mds.25844 · Cited by 502 · see citing works

THE BRAIN-STEM LESIONS IN PARKINSONISM

GREENFIELD, J. G., & Bosanquet, F. D. (1953) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.16.4.213 · Cited by 494 · see citing works

Axon degeneration in Parkinson's disease

Burke, R. E., & O’Malley, K. L. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.01.011 · Cited by 494 · see citing works

Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism

Hauser, D. N., & Hastings, T. G. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.10.011 · Cited by 470 · see citing works

Assembly-dependent endocytosis and clearance of extracellular a-synuclein

Lee, H.-J., Suk, J.-E., Bae, E.-J., Lee, J.-H., Paik, S. R., & Lee, S.-J. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.01.017 · Cited by 470 · see citing works

A novel α-synuclein missense mutation in Parkinson disease

Proukakis, C., Dudzik, C. G., Brier, T., Mackay, D. S., Cooper, J. A. D., Millhauser, G. L., Houlden, H., & Schapira, A. H. V. (2013) · Neurology · doi:10.1212/wnl.0b013e31828727ba · Cited by 465 · see citing works

Axonal -synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease

Orimo, S., Uchihara, T., Nakamura, A., Mori, F., Kakita, A., Wakabayashi, K., & Takahashi, H. (2007) · Brain · doi:10.1093/brain/awm302 · Cited by 462 · see citing works

α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson’s disease and multiple system atrophy?

Kiely, A. P., Asi, Y. T., Kara, E., Limousin, P. D., Ling, H., Lewis, P. A., Proukakis, C., Quinn, N. P., Lees, A. J., Hardy, J., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1096-7 · Cited by 450 · see citing works

Neuropathology of sporadic Parkinson's disease: Evaluation and changes of concepts

Jellinger, K. A. (2011) · Movement Disorders · doi:10.1002/mds.23795 · Cited by 448 · see citing works

Clearance of α-Synuclein Oligomeric Intermediates via the Lysosomal Degradation Pathway

Lee, H.-J., Khoshaghideh, F., Patel, S., & Lee, S.-J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3809-03.2004 · Cited by 445 · see citing works

Living on the edge with too many mouths to feed: Why dopamine neurons die

Bolam, J. P., & Pissadaki, E. K. (2012) · Movement Disorders · doi:10.1002/mds.25135 · Cited by 439 · see citing works

Recent Advances in the Genetics of Parkinson's Disease

Martin, I., Dawson, V. L., & Dawson, T. M. (2011) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-082410-101440 · Cited by 438 · see citing works

Transmission of multiple system atrophy prions to transgenic mice

Watts, J. C., Giles, K., Oehler, A., Middleton, L. T., Dexter, D. T., Gentleman, S., DeArmond, S. J., & Prusiner, S. B. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318268110 · Cited by 433 · see citing works

Microscopic analysis of polymerization dynamics with individual actin filaments

Fujiwara, I., Takahashi, S., Tadakuma, H., Funatsu, T., & Ishiwata, S. (2002) · Nature Cell Biology · doi:10.1038/ncb841 · Cited by 420 · see citing works

Descending projections of the locus coeruleus and subcoeruleus/medial parabrachial nuclei in monkey: Axonal transport studies and dopamine-β-hydroxylase immunocytochemistry

Westlund, K. N., & Coulter, J. D. (1980) · Brain Research Reviews · doi:10.1016/0165-0173(80)90009-0 · Cited by 414 · see citing works

The progression of pathology in longitudinally followed patients with Parkinson’s disease

Halliday, G. M., Hely, M. A., Reid, W. G. J., & Morris, J. G. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0344-8 · Cited by 410 · see citing works

L-dopa therapy in Parkinson's disease: a critical review of nine years' experience.

Barbeau, A. (1969) · PubMed · Cited by 409 · see citing works

Nigrostriatal α-synucleinopathy induced by viral vector-mediated overexpression of human α-synuclein: A new primate model of Parkinson's disease

Kirik, D., Annett, L. E., Bürger, C., Muzyczka, N., Mandel, R. J., & Björklund, A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0536383100 · Cited by 404 · see citing works

Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder

Boeve, B. F., Silber, M. H., Ferman, T. J., Lin, S. C., Benarroch, E. E., Schmeichel, A. M., Ahlskog, J. E., Caselli, R. J., Jacobson, S., Sabbagh, M., et al. (2013) · Sleep Medicine · doi:10.1016/j.sleep.2012.10.015 · Cited by 393 · see citing works

Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration

Paumier, K. L., Luk, K. C., Manfredsson, F. P., Kanaan, N. M., Lipton, J. W., Collier, T. J., Steece‐Collier, K., Kemp, C. J., Celano, S. L., Schulz, E., et al. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.06.003 · Cited by 386 · see citing works

A critical evaluation of the Braak staging scheme for Parkinson's disease

Burke, R. E., Dauer, W. T., & Vonsattel, J. P. (2008) · Annals of Neurology · doi:10.1002/ana.21541 · Cited by 377 · see citing works

Prion-like acceleration of a synucleinopathy in a transgenic mouse model

Mougenot, A.-L. J., Nicot, S., Bencsik, A. A., Morignat, E., Verchère, J., Lakhdar, L., Legastelois, S., & Baron, T. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.06.022 · Cited by 375 · see citing works

The E46K Mutation in α-Synuclein Increases Amyloid Fibril Formation

Greenbaum, E. A., Graves, C. L., Mishizen-Eberz, A. J., Lupoli, M. A., Lynch, D. R., Englander, S. W., Axelsen, P. H., & Giasson, B. I. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411638200 · Cited by 370 · see citing works

Neuron‐to‐neuron transmission of α‐synuclein fibrils through axonal transport

Freundt, E. C., Maynard, N., Clancy, E. K., Roy, S., Bousset, L., Sourigues, Y., Covert, M. W., Melki, R., Kirkegaard, K., & Brahic, M. (2012) · Annals of Neurology · doi:10.1002/ana.23747 · Cited by 370 · see citing works

α-Synucleinopathy phenotypes

McCann, H., Stevens, C. H., Cartwright, H., & Halliday, G. M. (2014) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(13)70017-8 · Cited by 364 · see citing works

Aggregates from mutant and wild‐type α‐synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of β‐sheet and amyloid‐like filaments

El‐Agnaf, O. M. A., Jakes, R., Curran, M. D., Middleton, D., Ingenito, R., Bianchi, E., Pessi, A., Neill, D., & Wallace, A. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01418-5 · Cited by 363 · see citing works

A vector for expressing foreign genes in the brains and hearts of transgenic mice

Borchelt, D., Davis, J. A., Fischer, M., Lee, M. K., Slunt, H. H., Ratovitski, T., Regard, J. B., Copeland, N. G., Jenkins, N. A., Sisodia, S. S., et al. (1996) · Genetic Analysis Biomolecular Engineering · doi:10.1016/s1050-3862(96)00167-2 · Cited by 362 · see citing works

Pathological roles of α-synuclein in neurological disorders

Vekrellis, K., Xilouri, M., Emmanouilidou, E., Rideout, H. J., & Stefanis, L. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70213-7 · Cited by 359 · see citing works

Applicability of current staging/categorization of α-synuclein pathology and their clinical relevance

Parkkinen, L., Pirttilä, T., & Alafuzoff, I. I. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0346-6 · Cited by 357 · see citing works

The energy cost of action potential propagation in dopamine neurons: clues to susceptibility in Parkinson's disease

Pissadaki, E. K., & Bolam, J. P. (2013) · Frontiers in Computational Neuroscience · doi:10.3389/fncom.2013.00013 · Cited by 349 · see citing works

Accumulation of α-synuclein in the bowel of patients in the pre-clinical phase of Parkinson’s disease

Hilton, D., Stephens, M., Kirk, L., Edwards, P., Potter, R., Zajicek, J., Broughton, E., Hagan, H., & Carroll, C. (2014) · Acta Neuropathologica · doi:10.1007/s00401-013-1214-6 · Cited by 345 · see citing works

Clearance and deposition of extracellular α-synuclein aggregates in microglia

Lee, H.-J., Suk, J.-E., Bae, E.-J., & Lee, S.-J. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.05.045 · Cited by 343 · see citing works

Properties of native brain α-synuclein

Burré, J., Vivona, S., Diao, J., Sharma, M., Brünger, A. T., & Südhof, T. C. (2013) · Nature · doi:10.1038/nature12125 · Cited by 340 · see citing works

Seeded Aggregation and Toxicity of α-Synuclein and Tau

Nonaka, T., Watanabe, S., Iwatsubo, T., & Hasegawa, M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.148460 · Cited by 330 · see citing works

α‐Synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects

Bloch, A., Probst, A., Bissig, H., Adams, H., & Tolnay, M. (2006) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2006.00727.x · Cited by 330 · see citing works

Intramuscular injection of α-synuclein induces CNS α-synuclein pathology and a rapid-onset motor phenotype in transgenic mice

Sacino, A. N., Brooks, M., Thomas, M. A., McKinney, A. B., Lee, S., Regenhardt, R. W., McGarvey, N. H., Ayers, J. I., Notterpek, L. M., Borchelt, D., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321785111 · Cited by 328 · see citing works

Research in motion: the enigma of Parkinson's disease pathology spread

Brundin, P., Li, J., Holton, J. L., Lindvall, O., & Révész, T. (2008) · Nature reviews. Neuroscience · doi:10.1038/nrn2477 · Cited by 328 · see citing works

α-Synuclein Immunotherapy Blocks Uptake and Templated Propagation of Misfolded α-Synuclein and Neurodegeneration

Tran, H., Chung, C. H.-Y., Iba, M., Zhang, B., Trojanowski, J. Q., Luk, K. C., & Lee, V. M. ‐. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.05.033 · Cited by 324 · see citing works

Parkinson’s disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons

Braak, H., Sastre, M., Böhl, J., de Vos, R. A. I., & Tredici, K. D. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0193-x · Cited by 320 · see citing works

Neuronal vulnerability, pathogenesis, and Parkinson's disease

Sulzer, D. L., & Surmeier, D. J. (2012) · Movement Disorders · doi:10.1002/mds.25095 · Cited by 315 · see citing works

Lipid Binding Inhibits α-Synuclein Fibril Formation

Zhu, M., & Fink, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210136200 · Cited by 314 · see citing works

Diffuse Intracytoplasmic Ganglionic Inclusions (Lewy Type) Associated with Progressive Dementia and Quadriparesis in Flexion

Okazaki, H., Lipkin, L. E., & Aronson, S. M. (1961) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-196104000-00007 · Cited by 303 · see citing works

Alpha-synuclein and Protein Degradation Systems: a Reciprocal Relationship

Xilouri, M., Brekk, O. R., & Stefanis, L. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8341-2 · Cited by 299 · see citing works

Neuroanatomy and Pathology of Sporadic Parkinson's Disease

Braak, H., & Tredici, K. D. (2008) · Advances in anatomy, embryology and cell biology · doi:10.1007/978-3-540-79850-7 · Cited by 297 · see citing works

Mutation E46K increases phospholipid binding and assembly into filaments of human α‐synuclein

Choi, W., Zibaee, S., Jakes, R., Serpell, L. C., Davletov, B. A., Crowther, R. A., & Goedert, M. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.09.038 · Cited by 286 · see citing works

Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer

Tan, T. Z., Miow, Q. H., Huang, R. Y., Wong, M. K., Ye, J., Lau, J. A., Wu, M., Hadi, L. A., Soong, R., Choolani, M. A., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201201823 · Cited by 281 · see citing works

123I-MIBG myocardial scintigraphy for differentiating Parkinson’s disease from other neurodegenerative parkinsonism: A systematic review and meta-analysis

Orimo, S., Suzuki, M., Inaba, A., & Mizusawa, H. (2012) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2012.01.009 · Cited by 279 · see citing works

Alpha‐synuclein transfers from neurons to oligodendrocytes

Reyes, J. F., Rey, N. L., Bousset, L., Melki, R., Brundin, P., & Angot, É. (2013) · Glia · doi:10.1002/glia.22611 · Cited by 278 · see citing works

Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson’s disease brain

Roberts, R. F., Wade‐Martins, R., & Alegre‐Abarrategui, J. (2015) · Brain · doi:10.1093/brain/awv040 · Cited by 272 · see citing works

Human recombinant NACP/α-synuclein is aggregated and fibrillated in vitro: Relevance for Lewy body disease

Hashimoto, M., Hsu, L. J., Sisk, A., Xia, Y., Takeda, A., Sundsmo, M. P., & Masliah, E. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00514-9 · Cited by 267 · see citing works

Transfer of human α-synuclein from the olfactory bulb to interconnected brain regions in mice

Rey, N. L., Petit, G. H., Bousset, L., Melki, R., & Brundin, P. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1160-3 · Cited by 267 · see citing works

Lewy Bodies of Parkinson's Disease Contain Neurofilament Antigens

Goldman, J. E., Yen, S.-H. C., Chiu, F., & Peress, N. S. (1983) · Science · doi:10.1126/science.6308771 · Cited by 260 · see citing works

Molecular nexopathies: a new paradigm of neurodegenerative disease

Warren, J. D., Rohrer, J. D., Schott, J. M., Fox, N. C., Hardy, J., & Rossor, M. N. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.06.007 · Cited by 259 · see citing works

Caudo‐rostral brain spreading of α‐synuclein through vagal connections

Ulusoy, A., Rusconi, R., Pérez‐Revuelta, B. I., Musgrove, R. E., Helwig, M., Winzen‐Reichert, B., & Monte, D. A. D. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201302475 · Cited by 250 · see citing works

Pathological alpha-synuclein propagates through neural networks

Masuda‐Suzukake, M., Nonaka, T., Hosokawa, M., Kubo, M., Shimozawa, A., Akiyama, H., & Hasegawa, M. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0088-8 · Cited by 249 · see citing works

Molecular mechanisms of α-synuclein neurodegeneration

Waxman, E. A., & Giasson, B. I. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.09.013 · Cited by 241 · see citing works

The novel Parkinson's disease linked mutation G51D attenuates in vitro aggregation and membrane binding of -synuclein, and enhances its secretion and nuclear localization in cells

Fares, M.-B., Ait‐Bouziad, N., Dikiy, I., Mbefo, M. K., Jovi, A., Kiely, A. P., Holton, J. L., Lee, S., Gitler, A. D., Eliezer, D., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu165 · Cited by 241 · see citing works

Cutaneous neuropathy in Parkinson’s disease: a window into brain pathology

Doppler, K., Ebert, S., Üçeyler, N., Trenkwalder, C., Ebentheuer, J., Volkmann, J., & Sommer, C. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1284-0 · Cited by 239 · see citing works

Inflammation and α-Synuclein’s Prion-like Behavior in Parkinson's Disease—Is There a Link?

Tomé, C. M. L., Tyson, T., Rey, N. L., Grathwohl, S. A., Britschgi, M., & Brundin, P. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8267-8 · Cited by 237 · see citing works

Dysfunction of the locus coeruleus–norepinephrine system and related circuitry in Parkinson's disease-related dementia

Tredici, K. D., & Braak, H. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301817 · Cited by 237 · see citing works

Lewy bodies in cerebral cortex. Report of three cases

Kosaka, K. (1978) · Acta Neuropathologica · doi:10.1007/bf00690978 · Cited by 235 · see citing works

Are ubiquitination pathways central to Parkinson’s disease?

Giasson, B. I., & Lee, V. M.-Y. (2003) · Cell · doi:10.1016/s0092-8674(03)00509-9 · Cited by 234 · see citing works

Specificity and Regulation of Casein Kinase-Mediated Phosphorylation of ??-Synuclein

Waxman, E. A., & Giasson, B. I. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3186fc995 · Cited by 232 · see citing works

A Precipitating Role for Truncated α-Synuclein and the Proteasome in α-Synuclein Aggregation

Liu, C.-W., Giasson, B., Lewis, K. A., Lee, V., DeMartino, G., & Thomas, P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501508200 · Cited by 224 · see citing works

The distribution of Lewy bodies in pure autonomic failure: autopsy findings and review of the literature

Hague, K., Lento, P., Morgello, S., Caro, S., & Kaufmann, H. (1997) · Acta Neuropathologica · doi:10.1007/s004010050693 · Cited by 209 · see citing works

Dopaminergic Cell Loss Induced by Human A30P α -Synuclein Gene Transfer to the Rat Substantia Nigra

Klein, R. L., King, M. A., Hamby, M. E., & Meyer, E. M. (2002) · Human Gene Therapy · doi:10.1089/10430340252837206 · Cited by 209 · see citing works

Characterization of the Precursor Protein of the Non-Aβ Component of Senile Plaques (NACP) in the Human Central Nervous System

Irizarry, M. C., Kim, T., McNamara, M. J., Tanzi, R. E., George, J. M., Clayton, D. F., & Hyman, B. T. (1996) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199608000-00004 · Cited by 205 · see citing works

Induction of Neuronal Cell Death by Rab5A-dependent Endocytosis of α-Synuclein

Sung, J. Y., Kim, J., Paik, S. R., Park, J. H., Ahn, Y. S., & Chung, K. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101318200 · Cited by 200 · see citing works

Absence of α-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia

Miller, D. W., Johnson, J. M., Solano, S. M., Hollingsworth, Z. R., Standaert, D. G., & Young, A. B. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-005-0378-1 · Cited by 198 · see citing works

Silver diagnosis in neuropathology: principles, practice and revised interpretation

Uchihara, T. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0200-2 · Cited by 197 · see citing works

Regional Multiple Pathology Scores Are Associated with Cognitive Decline in L ewy Body Dementias

Howlett, D. R., Whitfield, D., Johnson, M. A., Attems, J., O'Brien, J. T., Aarsland, D., Lai, M. K. P., Lee, J. H., Chen, C., Ballard, C. G., et al. (2014) · Brain Pathology · doi:10.1111/bpa.12182 · Cited by 196 · see citing works

The Parkinson’s Disease-Associated H50Q Mutation Accelerates α-Synuclein Aggregation in Vitro

Ghosh, D., Mondal, M., Mohite, G. M., Singh, P. K., Ranjan, P., Arunagiri, A., Ghosh, S., Jha, N. N., Kumar, A., & Maji, S. K. (2013) · Biochemistry · doi:10.1021/bi400999d · Cited by 190 · see citing works

Mixed Brain Pathologies in Dementia: The BrainNet Europe Consortium Experience

Kovacs, G. G., Alafuzoff, I., Al-Sarraj, S., Arzberger, T., Bogdanovic, N., Capellari, S., Ferrer, I., Gelpi, E., Kövari, V., Kretzschmar, H., et al. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000161560 · Cited by 186 · see citing works

Parkinson’s disease is not associated with gastrointestinal myenteric ganglion neuron loss

Annerino, D. M., Arshad, S., Taylor, G. M., Adler, C., Beach, T., & Greene, J. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1040-2 · Cited by 185 · see citing works

Lewy pathology and neurodegeneration in premotor Parkinson's disease

Tredici, K. D., & Braak, H. (2012) · Movement Disorders · doi:10.1002/mds.24921 · Cited by 184 · see citing works

Do α-synuclein aggregates in autonomic plexuses predate Lewy body disorders?

Mínguez‐Castellanos, A., Chamorro, C. E., Sevilla, F. E., Ortega-Moreno, A., Rebollo, A. C., Gómez-Río, M., Concha, A., & Muñoz, D. G. (2007) · Neurology · doi:10.1212/01.wnl.0000264429.59379.d9 · Cited by 183 · see citing works

Evaluation of α-synuclein immunohistochemical methods used by invited experts

Beach, T. G., White, C. L., Hamilton, R. L., Duda, J. E., Iwatsubo, T., Dickson, D. W., Leverenz, J. B., Roncaroli, F., Buttini, M., Hladik, C. L., et al. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0409-8 · Cited by 182 · see citing works

The H50Q Mutation Enhances α-Synuclein Aggregation, Secretion, and Toxicity

Khalaf, O., Fauvet, B., Oueslati, A., Dikiy, I., Mahul‐Mellier, A., Ruggeri, F. S., Mbefo, M. K., Vercruysse, F., Dietler, G., Lee, S., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.553297 · Cited by 180 · see citing works

An antibody with high reactivity for disease-associated α-synuclein reveals extensive brain pathology

Kovács, G. G., Wagner, U., Dumont, B., Pikkarainen, M., Osman, A. A., Streichenberger, N., Leisser, I., Verchère, J., Baron, T., Alafuzoff, I. I., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0964-x · Cited by 170 · see citing works

Snaring the Function of α-Synuclein

Bonini, N. M., & Giasson, B. I. (2005) · Cell · doi:10.1016/j.cell.2005.10.017 · Cited by 162 · see citing works

The Newly Discovered Parkinson’s Disease Associated Finnish Mutation (A53E) Attenuates α-Synuclein Aggregation and Membrane Binding

Ghosh, D., Sahay, S., Ranjan, P., Salot, S., Mohite, G. M., Singh, P. K., Dwivedi, S., Carvalho, E. J., Banerjee, R., Kumar, A., et al. (2014) · Biochemistry · doi:10.1021/bi5010365 · Cited by 158 · see citing works

Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities

Berg, D., Lang, A. E., Postuma, R. B., Maetzler, W., Deuschl, G., Gasser, T., Siderowf, A. D., Schapira, A. H. V., Oertel, W. H., Obeso, J. A., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70047-4 · Cited by 158 · see citing works

Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain

Wakabayashi, K., Mori, F., Tanji, K., Orimo, S., & Takahashi, H. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0706-x · Cited by 156 · see citing works

Advances in Anatomy Embryology and Cell Biology

(2007) · Springer eBooks · doi:10.1007/978-3-540-32948-0_1 · Cited by 153 · see citing works

Brain Injection of α-Synuclein Induces Multiple Proteinopathies, Gliosis, and a Neuronal Injury Marker

Sacino, A. N., Brooks, M., McKinney, A. B., Thomas, M. A., Shaw, G., Golde, T. E., & Giasson, B. I. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.2102-14.2014 · Cited by 141 · see citing works

A Mitocentric View of Parkinson's Disease

Haelterman, N. A. T., Yoon, W. H., Sandoval, H., Jaiswal, M., Shulman, J. M., & Bellen, H. J. (2014) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-071013-014317 · Cited by 138 · see citing works

Rab11a and HSP90 Regulate Recycling of Extracellular α-Synuclein

Liu, J., Zhang, J., Shi, M. Y., Quinn, T. J., Bradner, J. M., Beyer, R., Chen, S., & Zhang, J. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.6202-08.2009 · Cited by 133 · see citing works

E46K Human α-Synuclein Transgenic Mice Develop Lewy-like and Tau Pathology Associated with Age-dependent, Detrimental Motor Impairment

Emmer, K. L., Waxman, E. A., Covy, J. P., & Giasson, B. I. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.247965 · Cited by 133 · see citing works

Divergent effects of the H50Q and G51D SNCA mutations on the aggregation of α‐synuclein

Rutherford, N. J., Moore, B. D., Golde, T. E., & Giasson, B. I. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12806 · Cited by 131 · see citing works

A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death

Greffard, S., Verny, M., Bonnet, A.-M., Seilhean, D., Hauw, J., & Duyckaerts, C. J. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.03.015 · Cited by 130 · see citing works

Essential Tremor Associated With Focal Nonnigral Lewy Bodies

Louis, E. D., Honig, L. S., Vonsattel, J. P., Maraganore, D. M., Borden, S., & Moskowitz, C. B. (2005) · Archives of Neurology · doi:10.1001/archneur.62.6.1004 · Cited by 127 · see citing works

Amino acid sequence motifs and mechanistic features of the membrane translocation of α‐synuclein

Ahn, K. J., Paik, S. R., Chung, K. C., & Kim, J. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03731.x · Cited by 123 · see citing works

A new dopaminergic nigro-olfactory projection

Höglinger, G. U., Alvarez‐Fischer, D., Arias-Carrión, Ó., Djufri, M., Windolph, A., Keber, U., Borta, A., Ries, V., Schwarting, R. K. W., Scheller, D., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1451-y · Cited by 122 · see citing works

Thinking laterally about neurodegenerative proteinopathies

Golde, T. E., Borchelt, D., Giasson, B. I., & Lewis, J. M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66029 · Cited by 121 · see citing works

Axonal degeneration as a therapeutic target in the CNS

Lingor, P., Koch, J. C., Tönges, L., & Bähr, M. (2012) · Cell and Tissue Research · doi:10.1007/s00441-012-1362-3 · Cited by 119 · see citing works

Amyloidogenic α-synuclein seeds do not invariably induce rapid, widespread pathology in mice

Sacino, A. N., Brooks, M., Thomas, M. A., McKinney, A. B., McGarvey, N. H., Rutherford, N. J., Ceballos‐Diaz, C., Robertson, J., Golde, T. E., & Giasson, B. I. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1268-0 · Cited by 115 · see citing works

Rapid eye movement sleep behavior disorder and subtypes in autopsy‐confirmed dementia with Lewy bodies

Dugger, B. N., Boeve, B. F., Murray, M. E., Parisi, J. E., Fujishiro, H., Dickson, D. W., & Ferman, T. J. (2011) · Movement Disorders · doi:10.1002/mds.24003 · Cited by 110 · see citing works

The nigrostriatal system in the presymptomatic and symptomatic stages in the MPTP monkey model: A PET, histological and biochemical study

Blesa, J., Pifl, C., Sánchez-González, M. Á., Carlos Juri, C., García‐Cabezas, M. Á., Adánez, R., Iglesias, E., Collantes, M., Peñuelas, I., Sánchez-Hernández, J. J., et al. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.05.018 · Cited by 107 · see citing works

Coincident thresholds of mutant protein for paralytic disease and protein aggregation caused by restrictively expressed superoxide dismutase cDNA

Wang, J., Xu, G. M., Slunt, H. H., Gonzales, V., Coonfield, M. L., Fromholt, D., Copeland, N. G., Jenkins, N. A., & Borchelt, D. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.06.005 · Cited by 106 · see citing works

Characterization of Hydrophobic Residue Requirements for α-Synuclein Fibrillization

Waxman, E. A., Mazzulli, J. R., & Giasson, B. I. (2009) · Biochemistry · doi:10.1021/bi900539p · Cited by 106 · see citing works

Immunological features of α‐synuclein in Parkinson's disease

Roodveldt, C., Christodoulou, J. C., & Dobson, C. M. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00450.x · Cited by 95 · see citing works

Assessment of α-Synuclein Pathology: A Study of the BrainNet Europe Consortium

Alafuzoff, I., Parkkinen, L., Al-Sarraj, S., Arzberger, T., Bell, J., Bodi, I., Bogdanovic, N., Budka, H., Ferrer, I., Gelpi, E., et al. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181633526 · Cited by 90 · see citing works

The black stuff and Konstantin Nikolaevich Tretiakoff

Lees, A. J., Selikhova, M. V., de Andrade, L. A. F., & Duyckaerts, C. J. (2008) · Movement Disorders · doi:10.1002/mds.21855 · Cited by 88 · see citing works

Molecular chaperones and protein folding as therapeutic targets in Parkinson’s disease and other synucleinopathies

Ebrahimi‐Fakhari, D., Saidi, L.-J., & Wahlster, L. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-79 · Cited by 86 · see citing works

Induction of CNS α-synuclein pathology by fibrillar and non-amyloidogenic recombinant α-synuclein

Sacino, A. N., Brooks, M., McGarvey, N. H., McKinney, A. B., Thomas, M. A., Levites, Y., Ran, Y., Golde, T. E., & Giasson, B. I. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-38 · Cited by 86 · see citing works

A novel, high‐efficiency cellular model of fibrillar α‐synuclein inclusions and the examination of mutations that inhibit amyloid formation

Waxman, E. A., & Giasson, B. I. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06592.x · Cited by 82 · see citing works

Characterization of antibodies that selectively detect α-synuclein in pathological inclusions

Waxman, E. A., Duda, J. E., & Giasson, B. I. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0375-1 · Cited by 79 · see citing works

Quantitative correlation between cardiac MIBG uptake and remaining axons in the cardiac sympathetic nerve in Lewy body disease

Takahashi, M., Ikemura, M., Oka, T., Uchihara, T., Wakabayashi, K., Kakita, A., Takahashi, H., Yoshida, M., Toru, S., Kobayashi, T., et al. (2015) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-310686 · Cited by 74 · see citing works

The Parkinson chimera

Lees, A. J. (2009) · Neurology · doi:10.1212/wnl.0b013e318198daec · Cited by 71 · see citing works

Alpha-synuclein spreading in M83 mice brain revealed by detection of pathological α-synuclein by enhanced ELISA

Bétemps, D., Verchère, J., Brot, S., Morignat, E., Bousset, L., Gaillard, D., Lakhdar, L., Melki, R., & Baron, T. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-29 · Cited by 71 · see citing works

α-Synuclein in the olfactory system in Parkinson’s disease: role of neural connections on spreading pathology

Úbeda‐Bañón, I., Saiz‐Sánchez, D., de la Rosa‐Prieto, C., & Martı́nez-Marcos, A. (2013) · Brain Structure and Function · doi:10.1007/s00429-013-0651-2 · Cited by 69 · see citing works

Controversies over the staging of α-synuclein pathology in Parkinson’s disease

Kalaitzakis, M. E., Graeber, M. B., Gentleman, S. M., & Pearce, R. K. B. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0381-3 · Cited by 68 · see citing works

The Effect of Prolonged Fixation Time on Immunohistochemical Staining of Common Neurodegenerative Disease Markers

Pikkarainen, M., MARTIKAINEN, P. M., & Alafuzoff, I. I. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181c6c13d · Cited by 68 · see citing works

Three‐Layered Structure Shared Between Lewy Bodies and Lewy Neurites—Three‐Dimensional Reconstruction of Triple‐Labeled Sections

Kanazawa, T., Uchihara, T., Takahashi, A., Nakamura, A., Orimo, S., & Mizusawa, H. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00140.x · Cited by 67 · see citing works

Incidental Lewy body disease restricted to the heart and stellate ganglia

Miki, Y., Mori, F., Wakabayashi, K., Kuroda, N., & Orimo, S. (2009) · Movement Disorders · doi:10.1002/mds.22775 · Cited by 67 · see citing works

Conformational templating of α-synuclein aggregates in neuronal-glial cultures

Sacino, A. N., Thomas, M. A., Ceballos‐Diaz, C., Cruz, P. E., Rosario, A. M., Lewis, J. M., Giasson, B. I., & Golde, T. E. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-17 · Cited by 66 · see citing works

Dysfunction of the autophagy/lysosomal degradation pathway is a shared feature of the genetic synucleinopathies

Manzoni, C., & Lewis, P. A. (2013) · The FASEB Journal · doi:10.1096/fj.12-223842 · Cited by 62 · see citing works

The human brain : in photographs and diagrams

Nolte, J., & Angevine, J. B. (2013) · Cited by 62 · see citing works

Alpha-synuclein’s degradation in vivo: Opening a new (cranial) window on the roles of degradation pathways in Parkinson disease

Ebrahimi-Fakhari, D., McLean, P. J., & Unni, V. K. (2012) · Autophagy · doi:10.4161/auto.8.2.18938 · Cited by 61 · see citing works

Cerebral type of Lewy body disease

Kosaka, K., Iseki, E., Odawara, T., & Yamamoto, T. (1996) · Neuropathology · doi:10.1111/j.1440-1789.1996.tb00152.x · Cited by 61 · see citing works

Induction of peripherin expression in subsets of brain neurons after lesion injury or cerebral ischemia

Beaulieu, J., Križ, J., & Julien, J. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02830-5 · Cited by 57 · see citing works

Pale Neurites, Premature α‐Synuclein Aggregates with Centripetal Extension from Axon Collaterals

Kanazawa, T., Adachi, E., Orimo, S., Nakamura, A., Mizusawa, H., & Uchihara, T. (2011) · Brain Pathology · doi:10.1111/j.1750-3639.2011.00509.x · Cited by 56 · see citing works

The Human Brain: in photographs and diagrams

Allen, C. H. (1995) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.59.3.345 · Cited by 55 · see citing works

Prominent Perikaryal Expression of α- and β-Synuclein in Neurons of Dorsal Root Ganglion and in Medullary Neurons

Giasson, B. I., Duda, J. E., Forman, M. S., Lee, V. M. ‐., & Trojanowski, J. Q. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7805 · Cited by 52 · see citing works

A Novel Mechanism of Interaction between α-Synuclein and Biological Membranes

Kim, Y. S., Laurine, E., Woods, W. S., & Lee, S. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.05.004 · Cited by 52 · see citing works

Die Katechinamine im Zentralnervensystem

Sano, I., Taniguchi, K., Gamo, T., Takesada, M., & Kakimoto, Y. (1960) · Journal of Molecular Medicine · doi:10.1007/bf01483607 · Cited by 51 · see citing works

α-Synuclein phosphorylation as a therapeutic target in Parkinson’s disease

Braithwaite, S. P., Stock, J. B., & Mouradian, M. M. (2012) · Reviews in the Neurosciences · doi:10.1515/revneuro-2011-0067 · Cited by 50 · see citing works

Alpha-synuclein synaptic pathology and its implications in the development of novel therapeutic approaches to cure Parkinson's disease

Bellucci, A., Navarria, L., Zaltieri, M., Missale, C., & Spano, P. (2011) · Brain Research · doi:10.1016/j.brainres.2011.11.031 · Cited by 48 · see citing works

Hyper-expression of human apolipoprotein E4 in astroglia and neurons does not enhance amyloid deposition in transgenic mice

Lesuisse, C. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.22.2525 · Cited by 45 · see citing works

Formaldehyde-fixed brain tissue from spontaneously ill α-synuclein transgenic mice induces fatal α-synucleinopathy in transgenic hosts

Schweighauser, M., Bacioglu, M., Fritschi, S. K., Shimshek, D. R., Kahle, P. J., Eisele, Y. S., & Jucker, M. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1360-5 · Cited by 40 · see citing works

The A53E α-synuclein pathological mutation demonstrates reduced aggregation propensity in vitro and in cell culture

Rutherford, N. J., & Giasson, B. I. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.04.022 · Cited by 38 · see citing works

No Direct Projection is Observed from the Substantia Nigra to the Dorsal Vagus Complex in the Rat

Wang, Z., Lian, H., Cai, Q.-Q., Song, H., Zhang, X., Zhou, L., Zhang, Y.-M., Zheng, L., & Zhu, J.-X. (2014) · Journal of Parkinson s Disease · doi:10.3233/jpd-130279 · Cited by 32 · see citing works

Lewy body variant of Alzheimer’s disease or cerebral type Lewy body disease? Two autopsy cases of presenile onset with minimal involvement of the brainstem

Yokota, O., Tsuchiya, K., Uchihara, T., Ujike, H., Terada, S., Takahashi, M., Kimura, Y., Ishizu, H., Akiyama, H., & Kuroda, S. (2007) · Neuropathology · doi:10.1111/j.1440-1789.2006.00736.x · Cited by 26 · see citing works

Parkinson's disease: Acquired frailty of archaic neural networks?

Diederich, N. J., & Parent, A. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.10.003 · Cited by 24 · see citing works

Genetic aspects of Parkinson's disease

Mizuno, Y., Hattori, N., & Mochizuki, H. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)83009-0 · Cited by 3 · see citing works

The Dynamics of α-Synuclein at the Nerve Terminal

Fortin, D. L., Nemani, V. M., & Edwards, R. H. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374028-1.00018-x · Cited by 1 · see citing works

Selective neuronal vulnerability in Parkinson disease

Surmeier, D. J., Obeso, J. A., & Halliday, G. M. (2017) · Nature reviews. Neuroscience · doi:10.1038/nrn.2016.178 · Cited by 1,120 · see citing works

Brain-first versus body-first Parkinson’s disease: a multimodal imaging case-control study

Horsager, J., Andersen, K. B., Knudsen, K., Skjærbæk, C., Fedorova, T. D., Okkels, N., Schaeffer, E., Bonkat, S. K., Geday, J., Otto, M., et al. (2020) · Brain · doi:10.1093/brain/awaa238 · Cited by 782 · see citing works

Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naive Parkinson's disease patients

Bedarf, J. R., Hildebrand, F., Coelho, L. P., Sunagawa, S., Bahram, M., Goeser, F., Bork, P., & Wüllner, U. (2017) · Genome Medicine · doi:10.1186/s13073-017-0428-y · Cited by 642 · see citing works

Determinants of dopaminergic neuron loss in Parkinson's disease

Surmeier, D. J. (2018) · FEBS Journal · doi:10.1111/febs.14607 · Cited by 455 · see citing works

Brain-First versus Gut-First Parkinson’s Disease: A Hypothesis

Borghammer, P., & Van Den Berge, N. (2019) · Journal of Parkinson’s Disease · doi:10.3233/jpd-191721 · Cited by 419 · see citing works

Review: Sporadic Parkinson's disease: development and distribution ofα‐synuclein pathology

Tredici, K. D., & Braak, H. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12298 · Cited by 396 · see citing works

Inoculation of α-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve

Uemura, N., Yagi, H., Uemura, M. T., Hatanaka, Y., Yamakado, H., & Takahashi, R. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0257-5 · Cited by 328 · see citing works

Molecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision Medicine

Kovács, G. G. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020189 · Cited by 321 · see citing works

In-vivo staging of pathology in REM sleep behaviour disorder: A multimodality imaging case-control study

Knudsen, K., Fedorova, T. D., Hansen, A. K., Sommerauer, M., Otto, M., Svendsen, K. B., Nahimi, A., Stokholm, M. G., Pavese, N., Beier, C. P., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30162-5 · Cited by 309 · see citing works

Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer’s disease and PART

Kaufman, S. K., Del Tredici, K., Thomas, T. L., Braak, H., & Diamond, M. I. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1855-6 · Cited by 259 · see citing works

The α-Synuclein Origin and Connectome Model (SOC Model) of Parkinson’s Disease: Explaining Motor Asymmetry, Non-Motor Phenotypes, and Cognitive Decline

Borghammer, P. (2021) · Journal of Parkinson's Disease · doi:10.3233/jpd-202481 · Cited by 259 · see citing works

Molecular biomarkers of Alzheimer's disease: progress and prospects

Lashley, T., Schott, J. M., Weston, P. S. J., Murray, C. E., Wellington, H., Keshavan, A., Foti, S. C., Foiani, M. S., Toombs, J., Rohrer, J. D., et al. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.031781 · Cited by 233 · see citing works

Neuropathological evidence of body-first vs. brain-first Lewy body disease

Borghammer, P., Horsager, J., Andersen, K. B., Berge, N. V. D., Raunio, A., Murayama, S., Parkkinen, L., & Myllykangas, L. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105557 · Cited by 218 · see citing works

Parkinson's Disease Is Not Simply a Prion Disorder

Surmeier, D. J., Obeso, J. A., & Halliday, G. M. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.1787-16.2017 · Cited by 186 · see citing works

From the prion-like propagation hypothesis to therapeutic strategies of anti-tau immunotherapy

Colin, M., Dujardin, S., Schraen-Maschke, S., Meno-Tetang, G., Duyckaerts, C., Courade, J.-P., & Buée, L. (2020) · Acta Neuropathologica · doi:10.1007/s00401-019-02087-9 · Cited by 187 · see citing works

α-Synuclein and astrocytes: tracing the pathways from homeostasis to neurodegeneration in Lewy body disease

Sorrentino, Z. A., Giasson, B. I., & Chakrabarty, P. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-01977-2 · Cited by 181 · see citing works

Brain-to-stomach transfer of α-synuclein via vagal preganglionic projections

Ulusoy, A., Phillips, R. J., Helwig, M., Klinkenberg, M., Powley, T. L., & Di Monte, D. A. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1661-y · Cited by 179 · see citing works

The emerging role of α-synuclein truncation in aggregation and disease

Sorrentino, Z. A., & Giasson, B. I. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.011743 · Cited by 173 · see citing works

A Cortical Pathogenic Theory of Parkinson’s Disease

Foffani, G., & Obeso, J. A. (2018) · Neuron · doi:10.1016/j.neuron.2018.07.028 · Cited by 161 · see citing works

Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson’s disease and other synucleinopathies

Magalhães, P., & Lashuel, H. A. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00357-0 · Cited by 157 · see citing works

Propagation of α-Synuclein Strains within Human Reconstructed Neuronal Network

Gribaudo, S., Tixador, P., Bousset, L., Fenyi, A., Lino, P., Melki, R., Peyrin, J., & Perrier, A. L. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.12.007 · Cited by 152 · see citing works

Blood–brain barrier alterations and their impact on Parkinson’s disease pathogenesis and therapy

Lau, K., Kotzur, R., & Richter, F. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00430-z · Cited by 165 · see citing works

How does parkinson's disease begin? Perspectives on neuroanatomical pathways, prions, and histology

Borghammer, P. (2017) · Movement Disorders · doi:10.1002/mds.27138 · Cited by 136 · see citing works

Hippocampal α-Synuclein in Dementia with Lewy Bodies Contributes to Memory Impairment and Is Consistent with Spread of Pathology

Adamowicz, D. H., Roy, S., Salmon, D. P., Galasko, D. R., Hansen, L. A., Masliah, E., & Gage, F. H. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.3047-16.2016 · Cited by 126 · see citing works

Loss of autophagy in dopaminergic neurons causes Lewy pathology and motor dysfunction in aged mice

Sato, S., Uchihara, T., Fukuda, T., Noda, S., Kondo, H., Saiki, S., Komatsu, M., Uchiyama, Y., Tanaka, K., & Hattori, N. (2018) · Scientific Reports · doi:10.1038/s41598-018-21325-w · Cited by 125 · see citing works

The Prion-Like Spreading of Alpha-Synuclein in Parkinson’s Disease: Update on Models and Hypotheses

Jan, A., Gonçalves, N. P., Vægter, C. B., Jensen, P. H., & Ferreira, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158338 · Cited by 126 · see citing works

α-Synuclein in Parkinson’s disease: causal or bystander?

Riederer, P. F., Berg, D., Casadei, N., Cheng, F., Claßen, J., Dresel, C., Jost, W. H., Krüger, R., Müller, T. H., Reichmann, H., et al. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02025-9 · Cited by 118 · see citing works

Ageing promotes pathological alpha-synuclein propagation and autonomic dysfunction in wild-type rats

Berge, N. V. D., Ferreira, N., Mikkelsen, T. W., Alstrup, A. K. O., Tamgüney, G., Karlsson, P., Terkelsen, A. J., Nyengaard, J. R., Jensen, P. H., & Borghammer, P. (2021) · Brain · doi:10.1093/brain/awab061 · Cited by 121 · see citing works

Dura mater is a potential source of Aβ seeds

Kovács, G. G., Lutz, M. I., Ricken, G., Ströbel, T., Höftberger, R., Preusser, M., Regelsberger, G., Hönigschnabl, S., Reiner, A., Fischer, P. A., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1565-x · Cited by 110 · see citing works

Current Treatments and New, Tentative Therapies for Parkinson’s Disease

Pardo-Moreno, T., García‐Morales, V., Suleiman‐Martos, N., Rivas-Domínguez, A., Mohamed-Mohamed, H., Ramos‐Rodríguez, J. J., Melguizo‐Rodríguez, L., & González‐Acedo, A. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030770 · Cited by 109 · see citing works

Diagnostic Criteria for Dementia with Lewy Bodies: Updates and Future Directions

Yamada, M., Komatsu, J., Nakamura, K., Sakai, K., Samuraki-Yokohama, M., Nakajima, K., & Yoshita, M. (2019) · Journal of Movement Disorders · doi:10.14802/jmd.19052 · Cited by 110 · see citing works

Neural connectivity predicts spreading of alpha-synuclein pathology in fibril-injected mouse models: Involvement of retrograde and anterograde axonal propagation

Mezias, C., Rey, N. L., Brundin, P., & Raj, A. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104623 · Cited by 106 · see citing works

The brain-first vs. body-first model of Parkinson’s disease with comparison to alternative models

Borghammer, P. (2023) · Journal of Neural Transmission · doi:10.1007/s00702-023-02633-6 · Cited by 104 · see citing works

TIA1 regulates the generation and response to toxic tau oligomers

Jiang, L., Ash, P. E. A., Maziuk, B. F., Ballance, H. I., Boudeau, S., Abdullatif, A. A., Orlando, M., Petrucelli, L., Ikezu, T., & Wolozin, B. L. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1937-5 · Cited by 99 · see citing works

The Contribution of Iron to Protein Aggregation Disorders in the Central Nervous System

Joppe, K., Roser, A., Maass, F., & Lingor, P. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00015 · Cited by 102 · see citing works

The 3D structure of lipidic fibrils of α-synuclein

Frieg, B., Antonschmidt, L., Dienemann, C., Geraets, J. A., Najbauer, E. E., Matthes, D., de Groot, B. L., Andreas, L. B., Becker, S., Griesinger, C., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34552-7 · Cited by 101 · see citing works

Robust Central Nervous System Pathology in Transgenic Mice following Peripheral Injection of α-Synuclein Fibrils

Ayers, J. I., Brooks, M., Rutherford, N. J., Howard, J. K., Sorrentino, Z. A., Riffe, C. J., & Giasson, B. I. (2016) · Journal of Virology · doi:10.1128/jvi.02095-16 · Cited by 94 · see citing works

Calcium, mitochondrial dysfunction and slowing the progression of Parkinson's disease

Surmeier, D. J., Halliday, G. M., & Simuni, T. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.08.001 · Cited by 99 · see citing works

Physiological C-terminal truncation of α-synuclein potentiates the prion-like formation of pathological inclusions

Sorrentino, Z. A., Vijayaraghavan, N., Gorion, K.-M. M., Riffe, C. J., Strang, K. H., Caldwell, J. D., & Giasson, B. I. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005603 · Cited by 94 · see citing works

From Cerebrospinal Fluid to Blood: The Third Wave of Fluid Biomarkers for Alzheimer’s Disease

Zetterberg, H., & Blennow, K. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-179926 · Cited by 94 · see citing works

Unique α-synuclein pathology within the amygdala in Lewy body dementia: implications for disease initiation and progression

Sorrentino, Z. A., Goodwin, M. S., Riffe, C. J., Dhillon, J.-K. S., Xia, Y., Gorion, K.-M. M., Vijayaraghavan, N., McFarland, K. N., Golbe, L. I., Yachnis, A. T., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0787-2 · Cited by 84 · see citing works

The Potential Role of Gut-Derived Inflammation in Multiple System Atrophy

Engen, P. A., Dodiya, H. B., Naqib, A. D., Forsyth, C. B., Green, S. J., Voigt, R. M., Kordower, J. H., Mutlu, E., Shannon, K. M., & Keshavarzian, A. (2017) · Journal of Parkinson s Disease · doi:10.3233/jpd-160991 · Cited by 84 · see citing works

Intrastriatal injection of α-synuclein can lead to widespread synucleinopathy independent of neuroanatomic connectivity

Sorrentino, Z. A., Brooks, M. M. T., Hudson, V., Rutherford, N. J., Golde, T. E., Giasson, B. I., & Chakrabarty, P. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0182-z · Cited by 79 · see citing works

Designer protein disaggregases to counter neurodegenerative disease

Shorter, J. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2017.01.008 · Cited by 72 · see citing works

Proteolysis of α‐synuclein fibrils in the lysosomal pathway limits induction of inclusion pathology

Sacino, A. N., Brooks, M., Chakrabarty, P., Saha, K., Khoshbouei, H., Golde, T. E., & Giasson, B. I. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13743 · Cited by 67 · see citing works

Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy

Schaser, A. J., Stackhouse, T. L., Weston, L. J., Kerstein, P. C., Osterberg, V. R., López, C. S., Dickson, D. W., Luk, K. C., Meshul, C. K., Woltjer, R. L., et al. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01026-0 · Cited by 62 · see citing works

A53T-α-synuclein overexpression in murine locus coeruleus induces Parkinson’s disease-like pathology in neurons and glia

Henrich, M. T., Geibl, F. F., Lee, B., Chiu, W., Koprich, J. B., Brotchie, J. M., Timmermann, L., Decher, N., Matschke, L. A., & Oertel, W. H. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0541-1 · Cited by 65 · see citing works

Activity of translation regulator eukaryotic elongation factor-2 kinase is increased in Parkinson disease brain and its inhibition reduces alpha synuclein toxicity

Jan, A., Jansonius, B., Delaidelli, A., Bhanshali, F., An, Y. A., Ferreira, N., Smits, L. M., Negri, G. L., Schwamborn, J. C., Jensen, P. H., et al. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0554-9 · Cited by 66 · see citing works

Mathematical Modeling of Protein Misfolding Mechanisms in Neurological Diseases: A Historical Overview

Carbonell, F., Iturria‐Medina, Y., & Evans, A. C. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00037 · Cited by 63 · see citing works

Is Lewy pathology in the human nervous system chiefly an indicator of neuronal protection or of toxicity?

Chartier, S., & Duyckaerts, C. J. (2018) · Cell and Tissue Research · doi:10.1007/s00441-018-2854-6 · Cited by 63 · see citing works

Revisiting the specificity and ability of phospho-S129 antibodies to capture alpha-synuclein biochemical and pathological diversity

Lashuel, H. A., Mahul‐Mellier, A., Novello, S., Hegde, R. N., Jasiqi, Y., Altay, M. F., Donzelli, S., DeGuire, S. M., Burai, R., Magalhães, P., et al. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00388-7 · Cited by 61 · see citing works

Applying fluid biomarkers to Alzheimer's disease

Zetterberg, H. (2017) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00007.2017 · Cited by 62 · see citing works

Cervical skin denervation associates with alpha‐synuclein aggregates in Parkinson disease

Melli, G., Vacchi, E., Biemmi, V., Galati, S., Staedler, C., Ambrosini, R., & Kaelin‐Lang, A. (2018) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.669 · Cited by 61 · see citing works

Metagenomics of the Gut Microbiome in Parkinson's Disease: Prodromal Changes

Palacios, N., Wilkinson, J., Bjornevik, K., Schwarzschild, M. A., McIver, L., Ascherio, A., & Huttenhower, C. (2023) · Annals of Neurology · doi:10.1002/ana.26719 · Cited by 59 · see citing works

Novel antibodies to phosphorylated α-synuclein serine 129 and NFL serine 473 demonstrate the close molecular homology of these epitopes

Rutherford, N. J., Brooks, M., & Giasson, B. I. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0357-9 · Cited by 55 · see citing works

A novel panel of α-synuclein antibodies reveal distinctive staining profiles in synucleinopathies

Dhillon, J.-K. S., Riffe, C. J., Moore, B. D., Ran, Y., Chakrabarty, P., Golde, T. E., & Giasson, B. I. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184731 · Cited by 56 · see citing works

Pathogenic Mutations Differentially Regulate Cell-to-Cell Transmission of α-Synuclein

Guan, Y., Zhao, X., Liu, F., Yan, S., Wang, Y., Du, C., Cui, X., Li, R., & Zhang, C. X. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00159 · Cited by 54 · see citing works

An order in Lewy body disorders: Retrograde degeneration in hyperbranching axons as a fundamental structural template accounting for focal/multifocal Lewy body disease

Uchihara, T. (2016) · Neuropathology · doi:10.1111/neup.12348 · Cited by 55 · see citing works

Propagation of Aβ, tau and α-synuclein pathology between experimental models and human reality: prions, propagons and propaganda

Uchihara, T., Giasson, B. I., & Paulus, W. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1517-x · Cited by 55 · see citing works

Inflammatory pre-conditioning restricts the seeded induction of α-synuclein pathology in wild type mice

Koller, E. J., Brooks, M., Golde, T. E., Giasson, B. I., & Chakrabarty, P. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0142-z · Cited by 54 · see citing works

Motor neuron loss and neuroinflammation in a model of α-synuclein-induced neurodegeneration

Sorrentino, Z. A., Xia, Y., Funk, C., Riffe, C. J., Rutherford, N. J., Ceballos Diaz, C., Sacino, A. N., Price, N. D., Golde, T. E., Giasson, B. I., et al. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.09.005 · Cited by 54 · see citing works

Microbes Tickling Your Tummy: the Importance of the Gut-Brain Axis in Parkinson’s Disease

Perez‐Pardo, P., Hartog, M., Garssen, J., & Kraneveld, A. D. (2017) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-017-0129-2 · Cited by 52 · see citing works

Tau and Alpha Synuclein Synergistic Effect in Neurodegenerative Diseases: When the Periphery Is the Core

Vacchi, E., Kaelin‐Lang, A., & Melli, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145030 · Cited by 50 · see citing works

Gastrointestinal disorders in Parkinson’s disease and other Lewy body diseases

Hirayama, M., Nishiwaki, H., Hamaguchi, T., & Ohno, K. (2023) · npj Parkinson s Disease · doi:10.1038/s41531-023-00511-2 · Cited by 51 · see citing works

Cholinergic changes in Lewy body disease: implications for presentation, progression and subtypes

Okkels, N., Grothe, M. J., Taylor, J., Hasselbalch, S. G., Fedorova, T. D., Knudsen, K., van der Zee, S., van Laar, T., Bohnen, N. I., Borghammer, P., et al. (2024) · Brain · doi:10.1093/brain/awae069 · Cited by 52 · see citing works

Parkinson's disease: Is it a consequence of human brain evolution?

Diederich, N. J., Surmeier, D. J., Uchihara, T., Grillner, S. E., & Goetz, C. G. (2019) · Movement Disorders · doi:10.1002/mds.27628 · Cited by 49 · see citing works

Neuropathology of Nonmotor Symptoms of Parkinson's Disease

Jellinger, K. A. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.05.005 · Cited by 47 · see citing works

Clinical Phenotypes of Parkinson’s Disease Associate with Distinct Gut Microbiota and Metabolome Enterotypes

Vascellari, S., Melis, M., Palmas, V., Pisanu, S., Serra, A., Perra, D., Santoru, M. L., Oppo, V., Cusano, R., Uva, P., et al. (2021) · Biomolecules · doi:10.3390/biom11020144 · Cited by 48 · see citing works

Extracellular Alpha-Synuclein: Mechanisms for Glial Cell Internalization and Activation

Chavarría, C., Ivagnes, R., & Souza, J. M. (2022) · Biomolecules · doi:10.3390/biom12050655 · Cited by 47 · see citing works

Manganese and related neurotoxic pathways: A potential therapeutic target in neurodegenerative diseases

Chib, S., & Singh, S. (2022) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2022.107124 · Cited by 47 · see citing works

Comparative analyses of the in vivo induction and transmission of α-synuclein pathology in transgenic mice by MSA brain lysate and recombinant α-synuclein fibrils

Dhillon, J.-K. S., Trejo‐Lopez, J. A., Riffe, C. J., Levites, Y., Sacino, A. N., Borchelt, D., Yachnis, A. T., & Giasson, B. I. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0733-3 · Cited by 43 · see citing works

α-Synuclein-induced dysregulation of neuronal activity contributes to murine dopamine neuron vulnerability

Dagra, A., Miller, D. R., Lin, M., Gopinath, A., Shaerzadeh, F., Harris, S., Sorrentino, Z. A., Støier, J. F., Velasco, S., Azar, J., et al. (2021) · npj Parkinson s Disease · doi:10.1038/s41531-021-00210-w · Cited by 47 · see citing works

Localized Induction of Wild-Type and Mutant Alpha-Synuclein Aggregation Reveals Propagation along Neuroanatomical Tracts

Ayers, J. I., Riffe, C. J., Sorrentino, Z. A., Diamond, J., Fagerli, E., Brooks, M., Galaleldeen, A., Hart, P. J., & Giasson, B. I. (2018) · Journal of Virology · doi:10.1128/jvi.00586-18 · Cited by 40 · see citing works

A new alpha-synuclein missense variant (Thr72Met) in two Turkish families with Parkinson's disease

Fevga, C., Park, Y., Lohmann, E., Kievit, A. J. A., Breedveld, G. J., Ferraro, F., de Boer, L., van Minkelen, R., Hanagasi, H. A., Boon, A. J. W., et al. (2021) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2021.06.023 · Cited by 39 · see citing works

Current concepts and controversies in the pathogenesis of Parkinson’s disease dementia and Dementia with Lewy Bodies

Weil, R. S., Lashley, T., Brás, J., Schrag, A. E., & Schott, J. M. (2017) · F1000Research · doi:10.12688/f1000research.11725.1 · Cited by 41 · see citing works

Focused ultrasound in Parkinson's disease: A twofold path toward disease modification

Foffani, G., Trigo-Damas, I., Pineda-Pardo, J., Blesa, J., Rodríguez-Rojas, R., Martínez-Fernández, R., & Obeso, J. (2019) · Movement Disorders · doi:10.1002/mds.27805 · Cited by 36 · see citing works

Motor Progression and Nigrostriatal Neurodegeneration in Parkinson Disease

Furukawa, K., Shima, A., Kambe, D., Nishida, A., Wada, I., Sakamaki‐Tsukita, H., Yoshimura, K., Terada, Y., Sakato, Y., Mitsuhashi, M., et al. (2022) · Annals of Neurology · doi:10.1002/ana.26373 · Cited by 41 · see citing works

Impact of aging on animal models of Parkinson's disease

Klæstrup, I. H., Just, M. K., Holm, K. L., Alstrup, A. K. O., Romero‐Ramos, M., Borghammer, P., & Berge, N. V. D. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.909273 · Cited by 42 · see citing works

The Evolution-Driven Signature of Parkinson’s Disease

Diederich, N. J., Uchihara, T., Grillner, S. E., & Goetz, C. G. (2020) · Trends in Neurosciences · doi:10.1016/j.tins.2020.05.001 · Cited by 40 · see citing works

Modeling Parkinson's disease‐related symptoms in alpha‐synuclein overexpressing mice

Aniszewska, A., Bergström, J. J. E., Ingelsson, M., & Ekmark‐Lewén, S. (2022) · Brain and Behavior · doi:10.1002/brb3.2628 · Cited by 37 · see citing works

Glucocerebrosidase haploinsufficiency in A53T α-synuclein mice impacts disease onset and course

Tayebi, N., Parisiadou, L., Berhe, B. A., Gonzalez, A. N., Serra‐Vinardell, J., Tamargo, R., Maniwang, E., Sorrentino, Z. A., Fujiwara, H., Grey, R. J., et al. (2017) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2017.11.001 · Cited by 39 · see citing works

α-Synuclein pathology in Parkinson disease activates homeostatic NRF2 anti-oxidant response

Delaidelli, A., Richner, M., Jiang, L., van der Laan, A., Christiansen, I. B. J., Ferreira, N., Nyengaard, J. R., Vægter, C. B., Jensen, P. H., Mackenzie, I. R., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01209-3 · Cited by 39 · see citing works

Microbiome–gut–brain dysfunction in prodromal and symptomatic Lewy body diseases

Ryman, S. G., Vakhtin, A. A., Richardson, S. P., & Lin, H. C. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11461-9 · Cited by 38 · see citing works

Differentiating Dementia with Lewy Bodies and Alzheimer's Disease by Deep Learning to Structural MRI

Nemoto, K., Sakaguchi, H., Kasai, W., Hotta, M., Kamei, R., Noguchi, T., Minamimoto, R., Arai, T., & Asada, T. (2021) · Journal of Neuroimaging · doi:10.1111/jon.12835 · Cited by 37 · see citing works

Reconstruction of directed neuronal networks in a microfluidic device with asymmetric microchannels

Courte, J., Renault, R., Jan, A., Viovy, J., Peyrin, J., & Villard, C. (2018) · Methods in cell biology · doi:10.1016/bs.mcb.2018.07.002 · Cited by 37 · see citing works

Bidirectional Relationship Between Sleep Disturbances and Parkinson's Disease

Minakawa, E. N. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.927994 · Cited by 35 · see citing works

Comparison of the in vivo induction and transmission of α-synuclein pathology by mutant α-synuclein fibril seeds in transgenic mice

Rutherford, N. J., Dhillon, J.-K. S., Riffe, C. J., Howard, J. K., Brooks, M., & Giasson, B. I. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx371 · Cited by 33 · see citing works

Disease-, region- and cell type specific diversity of α-synuclein carboxy terminal truncations in synucleinopathies

Hass, E. W., Sorrentino, Z. A., Xia, Y., Lloyd, G. M., Trojanowski, J. Q., Prokop, S., & Giasson, B. I. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01242-2 · Cited by 34 · see citing works

Mild cognitive impairment in Parkinson's disease: current view

Jellinger, K. A. (2024) · Frontiers in Cognition · doi:10.3389/fcogn.2024.1369538 · Cited by 36 · see citing works

α-Synuclein oligomers potentiate neuroinflammatory NF-κB activity and induce Cav3.2 calcium signaling in astrocytes

Λεάνδρου, Ε., Chalatsa, I., Anagnostou, D., Machalia, C., Semitekolou, M., Filippa, V., Makridakis, M., Vlahou, A., Anastasiadou, E., Vekrellis, K., et al. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00401-4 · Cited by 31 · see citing works

Familial Mutations May Switch Conformational Preferences in α-Synuclein Fibrils

Xu, L., Ma, B., Nussinov, R., & Thompson, D. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00406 · Cited by 31 · see citing works

Current Management and Emerging Therapies in Multiple System Atrophy

Burns, M. R., & McFarland, N. R. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00890-x · Cited by 32 · see citing works

Robust α-synuclein pathology in select brainstem neuronal populations is a potential instigator of multiple system atrophy

Hass, E. W., Sorrentino, Z. A., Lloyd, G. M., McFarland, N. R., Prokop, S., & Giasson, B. I. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01173-y · Cited by 31 · see citing works

Toll-like Receptor 4 Is Upregulated in Parkinson’s Disease Patients and Co-Localizes with pSer129αSyn: A Possible Link with the Pathology

Conte, C., Ingrassia, A. M. T., Brevé, J. J. P., Bol, J. G. J. M., Huisman, E., van Dam, A., Beccari, T., & van de Berg, W. D. J. (2023) · Cells · doi:10.3390/cells12101368 · Cited by 32 · see citing works

Effect of Levodopa Initiation on the Gut Microbiota in Parkinson's Disease

Palacios, N., Hannoun, A., Flahive, J., Ward, D. V., Goostrey, K. J., Deb, A., & Smith, K. M. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.574529 · Cited by 31 · see citing works

Dysfunction of motor cortices in Parkinson’s disease

Chu, H., Smith, Y., Lytton, W. W., Grafton, S. T., Villalba, R. M., Masilamoni, G. J., & Wichmann, T. (2024) · Cerebral Cortex · doi:10.1093/cercor/bhae294 · Cited by 32 · see citing works

Neuropathology of Lewy body dementia: Lewy-related pathology, α-synuclein oligomers, and comorbid pathologies

Sekiya, H., Matsubara, T., Deture, M. A., & Dickson, D. W. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00900-6 · Cited by 30 · see citing works

Histone Deacetylase 6 and the Disease Mechanisms of α-Synucleinopathies

Lemos, M., & Stefanova, N. (2020) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2020.586453 · Cited by 28 · see citing works

Unique seeding profiles and prion-like propagation of synucleinopathies are highly dependent on the host in human α-synuclein transgenic mice

Lloyd, G. M., Sorrentino, Z. A., Quintin, S. S., Gorion, K.-M. M., Bell, B. M., Paterno, G., Long, B., Prokop, S., & Giasson, B. I. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02425-4 · Cited by 27 · see citing works

The Irony of Iron: The Element with Diverse Influence on Neurodegenerative Diseases

Lee, S., & Kovács, G. G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084269 · Cited by 30 · see citing works

Propagation of pathological α-synuclein by a prion-like mechanism

Tarutani, A., タルタニ, ア., & 樽谷愛理 (2017) · Institutional Repositories DataBase (IRDB)

Alpha-Synuclein

Hasegawa, M. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.08.126 · Cited by 1 · see citing works

α-synuclein (αS) in Parkinson's disease and related disorders

Hasegawa, M. (2018) · Proceedings for Annual Meeting of The Japanese Pharmacological Society · doi:10.1254/jpssuppl.wcp2018.0_sy54-4

Editorial

Kullmann, D. M. (2019) · Brain · doi:10.1093/brain/awz334

Beyond α-synuclein transfer: pathology propagation in Parkinson's disease

Hansen, C., & Li, J. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.03.002 · Cited by 82 · see citing works